Sun B, Ke K-B, Liu D-F, Wang Q, Li Y-N, Chen J-H, Zhang J-H
Chongming Branch Urology Surgery, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):10919. doi: 10.26355/eurrev_202011_23556.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613, by B. Sun, K.-B. Ke, D.-F. Liu, Q. Wang, Y.-N. Li, J.-H. Chen, J.-H. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (2): 633-638-DOI: 10.26355/eurrev_202001_20039-PMID: 32016964" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20039.
由于本文被怀疑存在研究不当行为，且通讯作者未回应我们要求证明数据和图表原创性的请求，B. Sun、K.-B. Ke、D.-F. Liu、Q. Wang、Y.-N. Li、J.-H. Chen、J.-H. Zhang发表于《欧洲医学与药理学评论》2020年；24(2): 633 - 638 - DOI: 10.26355/eurrev_202001_20039 - PMID: 32016964的《长链非编码RNA SNHG14通过靶向miR - 613在前列腺癌中作为癌基因发挥作用》已被撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/20039 。
